Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Janes

Showing results (251-260 of 275) with videos related to

Pageof 28
Sort By:
Nature Medicine|January 22, 2019
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesionsVitor H Teixeira, Christodoulos P Pipinikas, Adam Pennycuick, et al.
Iscience|November 17, 2022
Cell-intrinsic differences between human airway epithelial cells from children and adultsElizabeth F Maughan, Robert E Hynds, Adam Pennycuick, et al.
ERJ Open Research|April 3, 2023
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosisEyjolfur Gudmundsson, An Zhao, Nesrin Mogulkoc, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Science Immunology|December 15, 2023
Early human lung immune cell development and its role in epithelial cell fateJosephine L Barnes, Masahiro Yoshida, Peng He, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of the American Academy of Dermatology|April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Pageof 28

Showing results (251-260 of 275) with videos related to

Sort By:
Pageof 28
Nature Medicine|January 22, 2019
Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesionsVitor H Teixeira, Christodoulos P Pipinikas, Adam Pennycuick, et al.
Iscience|November 17, 2022
Cell-intrinsic differences between human airway epithelial cells from children and adultsElizabeth F Maughan, Robert E Hynds, Adam Pennycuick, et al.
ERJ Open Research|April 3, 2023
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosisEyjolfur Gudmundsson, An Zhao, Nesrin Mogulkoc, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Science Immunology|December 15, 2023
Early human lung immune cell development and its role in epithelial cell fateJosephine L Barnes, Masahiro Yoshida, Peng He, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of the American Academy of Dermatology|April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Pageof 28